United Therapeutics | UTHR - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Amarin USD 51.48M 113K 2025-12
Ardelyx USD 127.27M 7.15M 2026-03
Baxter International USD 2.68B 3.36B 2026-06
Bayer EUR 10.04B 168M 2026-06
BioCryst Pharmaceuticals USD 119.78M 673.63M 2026-06
Biogen USD 2.98B 1.02B 2026-06
BioMarin Pharmaceutical USD 6.32B 5.69B 2026-06
Emergent BioSolutions USD 555.9M 242.7M 2023-06
Gilead Sciences USD 3.95B 19.57B 2026-06
GlaxoSmithKline GBP 5.8B 468M 2026-06
Halozyme Therapeutics USD 193.34M 1.15M 2026-06
Insmed USD 526.79M 20.55M 2026-06
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
J&J USD 17.83B 388M 2026-06
Lexicon Pharmaceuticals USD 20.27M 6.1M 2025-12
Moderna USD 960M 817M 2026-06
Omeros USD 59.16M 20.13M 2024-06
Pfizer USD 85.19B 4.91B 2026-06
PTC Therapeutics USD 226.66M 19.64M 2026-03
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sarepta Therapeutics USD 387.96M 15.59M 2026-06
Teva Pharmaceutical Industries USD 3.92B 691M 2026-06
United Therapeutics USD 6.4B 499.2M 2026-06
Vertex Pharmaceuticals USD 2.07B 217.1M 2026-06